Willow Biosciences Valuation
| CANSF Stock | USD 0.03 0.01 40.00% |
Willow Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Willow Biosciences from examining the company fundamentals such as Shares Outstanding of 123.72 M, return on asset of -0.4, and Operating Margin of (62.65) % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors encourage locking in undervalued securities and disposing overvalued securities since, at some point, asset prices and their ongoing real values will grow together.
Overvalued
Today
Please note that Willow Biosciences' price fluctuation is out of control at this time. Calculation of the real value of Willow Biosciences is based on 3 months time horizon. Increasing Willow Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Willow otc stock is determined by what a typical buyer is willing to pay for full or partial control of Willow Biosciences. Since Willow Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Willow OTC Stock. However, Willow Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.028 | Real 0.0258 | Hype 0.03 | Naive 0.0248 |
The real value of Willow OTC Stock, also known as its intrinsic value, is the underlying worth of Willow Biosciences OTC Stock, which is reflected in its stock price. It is based on Willow Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Willow Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Willow Biosciences helps investors to forecast how Willow otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Willow Biosciences more accurately as focusing exclusively on Willow Biosciences' fundamentals will not take into account other important factors: Willow Biosciences Total Value Analysis
Willow Biosciences is currently projected to have takeover price of (3.21 M) with market capitalization of 10.43 M, debt of 607 K, and cash on hands of 23.04 M. The negative valuation of Willow Biosciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Willow Biosciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.21 M) | 10.43 M | 607 K | 23.04 M |
Willow Biosciences Investor Information
About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Willow Biosciences last dividend was issued on the 21st of May 2019. The entity had 1:25 split on the 21st of May 2019. Based on the key indicators related to Willow Biosciences' liquidity, profitability, solvency, and operating efficiency, Willow Biosciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Willow Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Willow Biosciences has an asset utilization ratio of 0.38 percent. This implies that the OTC Stock is making $0.003798 for each dollar of assets. An increasing asset utilization means that Willow Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Willow Biosciences Ownership Allocation
Willow Biosciences retains a total of 123.72 Million outstanding shares. Willow Biosciences owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Willow Biosciences Profitability Analysis
The company reported the revenue of 133 K. Net Loss for the year was (6.14 M) with profit before overhead, payroll, taxes, and interest of 111 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Willow Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Willow Biosciences and how it compares across the competition.
About Willow Biosciences Valuation
The otc valuation mechanism determines Willow Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Willow Biosciences. We calculate exposure to Willow Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Willow Biosciences's related companies.Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada. Willow Biosciences is traded on OTC Exchange in the United States.
8 Steps to conduct Willow Biosciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Willow Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Willow Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Willow Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Willow Biosciences' revenue streams: Identify Willow Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Willow Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Willow Biosciences' growth potential: Evaluate Willow Biosciences' management, business model, and growth potential.
- Determine Willow Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Willow Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Willow Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Willow Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 123.5 M | |
| Forward Price Earnings | 67.1141 | |
| Retained Earnings | -93.8 M |
Complementary Tools for Willow OTC Stock analysis
When running Willow Biosciences' price analysis, check to measure Willow Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Willow Biosciences is operating at the current time. Most of Willow Biosciences' value examination focuses on studying past and present price action to predict the probability of Willow Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Willow Biosciences' price. Additionally, you may evaluate how the addition of Willow Biosciences to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |